HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
etiroxate
RN given refers to (DL)-isomer
Also Known As:
CG 635; DL-alpha-methylthyroxine ethyl ester; Skleronorm; etiroxat; etiroxate hydrochloride; etiroxate, (L)-isomer; etiroxate, hydrochloride, (DL)-isomer
Networked:
9
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Hormones, Hormone Substitutes, and Hormone Antagonists
Hormones: 80400
Thyroid Hormones: 10782
Thyroxine: 10784
etiroxate: 9
Amino Acids, Peptides, and Proteins: 1
Amino Acids: 30675
Cyclic Amino Acids: 3
Aromatic Amino Acids: 467
Thyroxine: 10784
etiroxate: 9
Related Diseases
1.
Myocardial Infarction
09/17/1976 - "
The lipid-lowering effect of etiroxate was studied in a double-blind cross-over trial comprising 183 patients with hyperlipoproteinaemia, most of whom had suffered myocardial infarction or exhibited confirmed coronary insufficiency.
"
09/17/1976 - "
[The effect of etiroxate on serum lipids after myocardial infarction or in angina pectoris].
"
2.
Hyperlipoproteinemias
01/04/1980 - "
[Dose-response comparison with etiroxat HCl in hyperlipoproteinemias types IIa and IIb].
"
01/28/1977 - "
[Clinical experience with etiroxate hydrochloride in patients with primary hyperlipoproteinemia].
"
01/01/1982 - "
During a 4-month period of treatment etiroxate of hyperlipoproteinemia II and IV, the only significant change in plasma cholesterol level was a drop observed after the first two weeks; on the other hand, the turnover rate of cholesterol rose gradually and approached normal values due to a highly increased LCAT activity.
"
04/01/1982 - "
Rate of LCAT-mediated cholesterol esterification and serum lipids during etiroxate therapy in hyperlipoproteinemia.
"
04/17/1977 - "
[Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
"
3.
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
04/01/1981 - "
Six female patients with a primary hyperlipoproteinemia type IIa received 40 mg/day etiroxate for 2 months.
"
11/08/1979 - "
[Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl.
"
11/01/1975 - "
Ten out-patients with primary Type IIa hyperlipoproteinemia and a further 10 with Types IIb, IV, and V were administered with DL-alpha-methyl-thyroxine ethyl ester (etiroxate) (20 mg twice daily) for an average of 308 days.
"
4.
Angina Pectoris
09/17/1976 - "
[The effect of etiroxate on serum lipids after myocardial infarction or in angina pectoris].
"
Related Drugs and Biologics
1.
Lipids
2.
Cholesterol
3.
Triglycerides (Triacylglycerol)
4.
Thyroxine (Levothyroxine)
5.
Esters
6.
Clofibrate
Related Therapies and Procedures
1.
Therapeutics